Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07060794
PHASE4
Tafenoquine and ACTs (TADORE- Plus)
Sponsor: Menzies School of Health Research
View on ClinicalTrials.gov
Summary
A trial designed to determine whether there is a clinically significant drug-drug interaction of tafenoquine with DHA-piperaquine or artesunate-pyronaridine using a control arm with radical cure given at the end of follow up (delayed radical cure).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
507
Start Date
2026-06
Completion Date
2028-06
Last Updated
2026-03-18
Healthy Volunteers
No
Conditions
Interventions
DRUG
Tafenoquine plus DHA-Piperaquine
Tafenoquine plus DHA-piperaquine
DRUG
Tafenoquine plus Artesunate-pyronaridine
Tafenoquine plus Artesunate-pyronaridine